[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100147099":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":90,"centralContacts":95,"locations":102,"responsibleParty":108,"collaborators":112,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":120,"eligibilityCriteria":121,"healthyVolunteers":116,"sex":122,"minAge":123,"maxAge":10,"enrollmentInfo":124,"targetDuration":10,"studyType":127,"phases":10,"briefSummary":128,"conditions":129,"keywords":132,"overallStatus":105,"whyStopped":10,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":144},{"fullName":5,"class":6},"CardioVascular Research Foundation, Korea","OTHER",[8,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84,87],{"label":9,"type":10,"description":11,"interventionNames":10},"DESSIAN",null,"consecutive patients receiving CYPHER stent",{"label":13,"type":10,"description":14,"interventionNames":10},"K-XIENCE","consecutive patients receiving Xience stent",{"label":16,"type":10,"description":17,"interventionNames":10},"GENOUS","consecutive patients receiving GENOUS stent",{"label":19,"type":10,"description":20,"interventionNames":10},"ELEMENT","consecutive patients receiving PROMUS-ELEMENT stent",{"label":22,"type":10,"description":23,"interventionNames":10},"PRIME","consecutive patients receiving XIENCE-PRIME stent",{"label":25,"type":10,"description":26,"interventionNames":10},"NOBORI","consecutive patients receiving NOBORI stent",{"label":28,"type":10,"description":29,"interventionNames":10},"INTEGRITY","consecutive patients receiving RESOLUTE-INTEGRITY stent",{"label":31,"type":10,"description":32,"interventionNames":10},"XPEDITION","consecutive patients receiving XIENCE-XPEDITION stent",{"label":34,"type":10,"description":35,"interventionNames":10},"BIOMATRIX","consecutive patients receiving BIOMATRIX stent",{"label":37,"type":10,"description":38,"interventionNames":10},"CILOTAX","consecutive patients receiving CILOTAX stent",{"label":40,"type":10,"description":41,"interventionNames":10},"DEB","consecutive patients receiving Drug eluting balloon",{"label":43,"type":10,"description":44,"interventionNames":10},"DESYNE","consecutive patients receiving DESYNE stent",{"label":46,"type":10,"description":47,"interventionNames":10},"PREMIER","consecutive patients receiving PROMUS-PREMIER stent",{"label":49,"type":10,"description":50,"interventionNames":10},"ORSIRO","consecutive patients receiving ORSIRO stent",{"label":52,"type":10,"description":53,"interventionNames":10},"ONYX","consecutive patients receiving ONYX stent",{"label":55,"type":10,"description":56,"interventionNames":10},"BVS","consecutive patients receiving Bioresorbable Vascular Scaffold",{"label":58,"type":10,"description":59,"interventionNames":10},"BVS AMI","consecutive acute myocardial infarction patients receiving Bioresorbable Vascular Scaffold",{"label":61,"type":10,"description":62,"interventionNames":10},"Ultimaster","consecutive patients receiving Ultimaster stent",{"label":64,"type":10,"description":65,"interventionNames":10},"Synergy","consecutive patients receiving Synergy stent",{"label":67,"type":10,"description":68,"interventionNames":10},"Biofreedom","consecutive patients receiving Biofreedom stent",{"label":70,"type":10,"description":71,"interventionNames":10},"Firehawk","consecutive patients receiving Firehawk stent",{"label":73,"type":10,"description":74,"interventionNames":10},"DESyne X2","consecutive patients receiving DESyne X2 stent",{"label":76,"type":10,"description":77,"interventionNames":10},"Sierra","consecutive patients receiving Sierra stent",{"label":79,"type":10,"description":80,"interventionNames":10},"Tansei","consecutive patients receiving Tansei stent",{"label":82,"type":10,"description":83,"interventionNames":10},"Synergy XD and Synergy Megatron™","consecutive patients receiving Synergy XD or Synergy Megatron™ stent",{"label":85,"type":10,"description":86,"interventionNames":10},"Xience-Skypoint","consecutive patients receiving Xience-Skypoint stent",{"label":88,"type":10,"description":89,"interventionNames":10},"Coroflex ISAR NEO","consecutive patients receiving Coroflex ISAR NEO stent",[91],{"name":92,"affiliation":93,"role":94},"Seung-Jung Park, MD","Asan Medical Center","STUDY_CHAIR",[96,99],{"name":92,"role":97,"phone":10,"phoneExt":10,"email":98},"CONTACT","sjpark@amc.seoul.kr",{"name":100,"role":97,"phone":10,"phoneExt":10,"email":101},"Duk-Woo Park, MD","dwpark@amc.seoul.kr",[103],{"facility":104,"status":105,"city":106,"state":10,"zip":10,"country":107,"countryCode":10,"cosmosGeoPoint":10,"geoPoint":10,"contacts":10},"Korean centres","RECRUITING","Multiple Locations","South Korea",{"type":109,"investigatorFullName":110,"investigatorTitle":111,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Seung-Jung Park","MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine",[113],{"name":5,"class":6},"100147099","evaluation-of-the-first-second-and-new-drug-eluting-stents-in-routine-clinical-practice-100147099",false,"NCT01186133","Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice","Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice","IRIS-DES","Inclusion Criteria:\n\n* coronary disease amenable to percutaneous coronary intervention (PCI)\n* no clinical and lesion limitations\n\nExclusion Criteria:\n\n* patients with a mixture of several DES\n* terminal illness with life expectancy less than 1 year\n* patients with cardiogenic shock","ALL","19 Years",{"count":125,"type":126},50000,"ESTIMATED","OBSERVATIONAL","The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the \"real world\" daily practice.",[130,131],"Coronary Artery Disease","Percutaneous Transluminal Coronary Angioplasty",[133,134],"coronary disease","drug eluting stent","2026-06-26",{"date":137,"type":138},"2026-06-30","ACTUAL",{"date":140,"type":10},"2009-01",{"date":142,"type":126},"2030-12",{"name":110,"class":6},1]